Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy (Q42164528)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 October 2004
edit
Language Label Description Also known as
English
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
scientific article published on 31 October 2004

    Statements

    Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy (English)
    Anthony H Barnett
    Diabetics Exposed to Telmisartan and Enalapril Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit